The National Clinical Care Commission Report to Congress: Summary and Next Steps

Author:

Conlin Paul R.12ORCID,Boltri John M.3,Bullock Ann4,Greenlee M. Carol5,Lopata Aaron M.6,Powell Clydette7,Schillinger Dean8,Tracer Howard9,Herman William H.10ORCID

Affiliation:

1. 1Department of Veterans Affairs Boston Healthcare System, Boston, MA

2. 2Harvard Medical School, Boston, MA

3. 3Northeast Ohio Medical University, Rootstown, OH

4. 4Division of Diabetes Treatment and Prevention, Indian Health Service, Rockville, MD

5. 5Western Slope Endocrinology, Grand Junction, CO

6. 6Maternal and Child Health Bureau, Health Resources and Services Administration, Rockville, MD

7. 7School of Medicine and Health Services, George Washington University, Washington, DC

8. 8University of California San Francisco and San Francisco General Hospital, San Francisco, CA

9. 9Agency for Healthcare Research and Quality, Department of Health and Human Services, Rockville, MD

10. 10University of Michigan, Ann Arbor, MI

Abstract

The U.S. is experiencing an epidemic of type 2 diabetes. Socioeconomically disadvantaged and certain racial and ethnic groups experience a disproportionate burden from diabetes and are subject to disparities in treatment and outcomes. The National Clinical Care Commission (NCCC) was charged with making recommendations to leverage federal policies and programs to more effectively prevent and control diabetes and its complications. The NCCC determined that diabetes cannot be addressed simply as a medical problem but must also be addressed as a societal problem requiring social, clinical, and public health policy solutions. As a result, the NCCC’s recommendations address policies and programs of both non–health-related and health-related federal agencies. The NCCC report, submitted to the U.S. Congress on 6 January 2022, makes 39 specific recommendations, including three foundational recommendations that non–health-related and health-related federal agencies coordinate their activities to better address diabetes, that all federal agencies and departments ensure that health equity is a guiding principle for their policies and programs that impact diabetes, and that all Americans have access to comprehensive and affordable health care. Specific recommendations are also made to improve general population-wide policies and programs that impact diabetes risk and control, to increase awareness and prevention efforts among those at high risk for type 2 diabetes, and to remove barriers to access to effective treatments for diabetes and its complications. Finally, the NCCC recommends that an Office of National Diabetes Policy be established to coordinate the activities of health-related and non–health-related federal agencies to address diabetes prevention and treatment. The NCCC urges Congress and the Secretary of Health and Human Services to implement these recommendations to protect the health and well-being of the more than 130 million Americans at risk for and living with diabetes.

Funder

Office of Minority Health

Centers for Disease Control and Prevention

Centers for Medicare and Medicaid Services

Agency for Healthcare Research and Quality

National Institutes of Health

Food and Drug Administration

Health Resources and Services Administration

Indian Health Service

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference13 articles.

1. The National Clinical Care Commission report to Congress: recommendations to better leverage federal policies and programs to prevent and control diabetes;Herman;Diabetes Care,2023

2. National Clinical Care Commission . Report to Congress on Leveraging Federal Programs to Prevent and Control Diabetes and Its Complications, 2021. Chapter 1. Background. Accessed 19 July 2022. Available from https://health.gov/about-odphp/committees-workgroups/national-clinical-care-commission/report-congress

3. Social determinants of health and diabetes: a scientific review;Hill-Briggs;Diabetes Care,2020

4. The National Clinical Care Commission report to Congress: background, methods, and foundational recommendations;Herman;Diabetes Care,2023

5. Health impact assessment;Lock;BMJ,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3